Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin - E. Lopez; J O Lundberg; F. Hieronymus; M. Beckman; H. Yngwe; C.J. Ekman; M. Tiger; N. Edvall (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic study - I. Totomanova; E.C.H.M. Haijen; P.P.M. Hurks; NL Mason; JG Ramaekers; K.P.C. Kuypers (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adults - Y. Ge; T.P. Whelan; M. Dimitrov; C.L. Ellis; F. Moruzzi; J. Kangas; F.M. Ponteduro; N. Khalil; S. Fenn-Moltu; NA Puts; E. Daly; D.G.M. Murphy; et al. (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Electrical brain changes following psilocybin administration in sprague-dawley rats - B. Richardson; V. Bruno; J. O'Byrne; G. Gobbi (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic people - T. Whelan; M. Dimitrov; C.L. Ellis; F. Moruzzi; J. Kangas; N. Khalil; G. Ivin; E. Daly; NA Puts; D.G.M. Murphy; G.M. McAlonan (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial - L.J. Mertens; M. Koslowski; F. Betzler; M. Brand; R. Evens; L. Krätner; A. Jungaberle; H. Jungaberle; T. Majić; C.N. Schmitz; A. Ströhle; D. Scharf; et al. (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial - L. Marwood; M. Young; J. Chai-Rees; S. Mistry; S. Maxwell; G.M. Goodwin (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model - I.R.A. Koutrouli; K. Šíchová; W. Kacper; V. Brejtr; K. Aleksič; N. Miniariková; E. Lhotková; M. Nikolič; T. Páleníček (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes - N. Mcgowan; J. Rucker; R. Yehuda; M. Agrawal; H. Simmons; S. Das; G. Goodwin (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression - L. Puhl; L. Kunz; M. Berger; G. Gründer; L. Mertens; M. Spangemacher (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Preclinical evaluation of psilocybin as an anti-inflammatory agent - N. Martínez-Álvarez; I. Erkizia-Santamaría; A. Tomás-Alvarado; A.M. Erdozain; J.J. Meana; J.E. Ortega (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music - M. Benes; D. Gregus; P. Adamek; T. Páleníček; J. Horacek (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adults - O. Ollari; T.P. Whelan; C.L. Ellis; N. Khalil; F. Moruzzi; D.G.M. Murphy; E. Daly; L. Mason; N. Puts; G.M. McAlonan (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in mice - F. Sellitti; C. Weber; É. Tamura; Z. Li; J. Thomann; D. Luethi; L.D. Simmler (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybin - I. Totomanova; E.C.H.M. Haijen; Petra P. M. Hurks; NL Mason; K.P.C. Kuypers (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in humans - A. O'shea; JG Ramaekers; R. Schreiber; J.J. Briedé; J. Krauskopf; N. Mason; M.C.T. Verheijen (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Behavioral and neuronal effects of psilocybin in mice - C. Weber; F. Sellitti; L. Ziming; J. von Arx; L.D. Simmler (Neuroscience Applied, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression - Rebecca Harding; Natalie Ertl; Rabia Zafar; Magnus Wall; Rajkanya Das; David Erritzøe; David Nutt; Robin Carhart-Harris (Neuroscience Applied, 2024)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior - Michal Brownstien (Neuroscience Applied, 2024)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Is there room for ethics of authenticity in psilocybin research? - Stefan Jerotić (Neuroscience Applied, 2024)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatment - Matthew B. Young; J. Chai-Rees; Anna Nowakowska; Jeng-Yu Tsai; Guy M. Goodwin (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin vs Escitalopram for depression: 6-month follow-up - Thomas Barba; David Erritzøe; Kyle T. Greenway; Rinki Murphy; John Martell; Christopher Timmermann; Ashleigh Murphy-Beiner; Bruna Giribaldi; Michelle Baker Jones; Brandon Weiss; Robin Carhart-Harris (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patients - Kristoffer Brendstrup-Brix; Patrick M. Fisher; Dea Siggaard Stenbæk; Anja Sofie Petersen; Stéphane Armand; Drummond E-Wen McCulloch; Maja Rou Marstrand-Joergensen; Sara Marie Ulv Larsen; Annette Johansen; Rigmor Jensen; Gitte M. Knudsen; M. Madsen (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Neural effects of psilocybin-treatment in patients with treatment-resistant depression - C. Schmitz; Hana Adolphi; Michael Frank; E. Seeger; Maciej Musiał; Moritz Spangemacher; Michael Koslowski; Lea J. Mertens; Florian Schlagenhauf; Gerhard Gründer (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female rats - Kyna-Anne Conn; Laura K Milton; Kaixin Huang; Hermany Munguba; Jaana Ruuska; Mónica Lemus; Erin Greaves; Jihane Homman-Ludiye; Brian J. Oldfield; Claire J. Foldi (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patients - L. Belinger; Flora Moujaes; Robin von Rotz; Nathalie M. Rieser; Marcus Herdener; Franz X. Vollenweider; Katrin H. Preller (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Evaluation of the long-term cognitive effects of psilocybin in a chronic stress mouse model - Nerea Martínez-Álvarez; Ines Erkizia-Santamaría; Elena Hernández-Hernández; Amaia M. Erdozain; J. Javier Meana; J.E. Ortega (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy - Agata Korlatowicz; Katarzyna Latocha; Paulina Pabian; Ryszard Bugno; Adam S. Hogendorf; Tamás Kovács; Andrzej J. Bojarski; Zoltán V. Varga; Agata Faron-Górecka (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousness - N. Hewitt; J. Chai-Rees; Megan Croal; S. Mistry; Jeng-Yu Tsai; Matthew B. Young; Guy M. Goodwin (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigs - Ewald Kolesnik; Ma Luisa Masó Navarro; Nakul Ravi Raval; Brice Ozenne; Hanne D. Hansen (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Safety pharmacology of acute psilocybin administration in healthy participants - Isabelle Straumann; Friederike Holze; A. Becker; Laura Ley; Nepomuk Halter; Matthias E. Liechti (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals - Sophia Armand; Kristian Larsen; M. Madsen; Brice Ozenne; Katrin H. Preller; Gitte M. Knudsen; Dea Siggaard Stenbæk; Patrick M. Fisher (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling - Klaus Richter Larsen; Ulrich Lindberg; Brice Ozenne; Drummond E-Wen McCulloch; Sophia Armand; M. Madsen; Annette Johansen; Dea Siggaard Stenbæk; Gitte M. Knudsen; Patrick M. Fisher (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model - Ines Erkizia-Santamaría; Guadalupe Rivero; Igor Horrillo; J. Javier Meana; Jorge E. Ortega (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study - Guy M. Goodwin; Lindsey Marwood; S. Mistry; Anna Nowakowska; Zainib Shabir; H. Clifton Simmons; E.K. Teoh; Jeng-Yu Tsai; E. Malievskaia (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression - Agata Machaczka; Jane Turek; Dorota Bederska-Łojewska; Bartłomiej Pochwat; Łukasz Gąsior; Bernadeta Szewczyk; Andrzej Pilc (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice - Sofia Nasini; Martina Colognesi; Sara Tidei; Sara De Martin; Marco Banzato; Andrea Mattarei; Franco Folli; P. Marco; Paolo L. Manfredi; Stefano Comai (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial - Guy M. Goodwin; Megan Croal; J. Chai-Rees; Lindsey Marwood; S. Mistry; Anna Nowakowska; H. Clifton Simmons; Jeng-Yu Tsai (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls - Miriam L. Navarro; Alberte Wollesen Breum; Annette Johansen; Brice Ozenne; Vibe G. Frøkjær; Gitte M. Knudsen (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteers - Drummond E-Wen McCulloch; Anders Smærup Olsen; Dea Siggaard Stenbæk; Sophia Armand; M. Madsen; Gitte M. Knudsen; Patrick M. Fisher (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Investigating changes in EEG entropy rate in response to psilocybin - a comparison of lempel ziv and state-space entropy rate measures - M. Nikolič; P. Mediano; Tom Froese; Tomáš Páleníček (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders. - O. Shahar; A. Botvinik; T. Lifschytz; B. Lerer (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results - Hannah Douglass; Merle Spriggs; Kate Godfrey; Jennifer L. Danby; Francisco Magalhães; Kirsty L. Alderton; Liane Macdonald; Stephanie Archer; Tim Read; Adèle Lafrance; Dasha Nicholls; David Erritzøe; et al. (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement - Vejmola Č.; Hubený J.; Koudelka V.; Griškova-Bulanova I.; Páleníček T. (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design. - Mertens LJ; Koslowski M; Betzler F; Evens R; Gilles M; Jungaberle A; Jungaberle H; Majić T; Ströhle A; Wolff M; Wellek S; Gründer G. (Neuroscience Applied, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans - Klaus Richter Larsen; Drummond E-Wen McCulloch; Brice Ozenne; Ulrich Lindberg; Sophia Armand; M. Madsen; Dea Siggaard Stenbæk; Gitte M. Knudsen; Patrick M. Fisher (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Neurochemical properties of psilocybin in comparison to ketamine in vivo - A. Wojtas; A. Bysiek; Z. Szych; M. Herian; K. Gołembiowska (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviour - E. Stojek; Jack Prenderville; F. Dunphy-Doherty (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Effects of psilocybin in relative and global cerebral blood flow and behavioural correlates - Nathalie M. Rieser; Ladina P Gubser; Franz X. Vollenweider; Meyer Lars; Katrin H. Preller (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice - Ines Erkizia-Santamaría; R. Alles-Pascual; Igor Horrillo; Albert Adell; J. Javier Meana; J.E. Ortega (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in rats - Lucie Olejníková; Klára Šíchová; K. Chona; Hynek Danda; Tomáš Páleníček (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The role of psilocybin in memory consolidation in the animal model - K. Šíchová; K. Chona; Lucie Olejníková Ladislavová; T. Páleníček (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Acute change in functional brain entropy following psilocybin administration in healthy volunteers - Drummond E-Wen McCulloch; Anders Smærup Olsen; Dea Siggaard Stenbæk; Sophia Armand; M.K. Madsen; Gitte M. Knudsen; Patrick M. Fisher (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjects - Friederike Holze; Laura Ley; F. Müller; V. Nimmy; Anne Eckert; Matthias E. Liechti (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder - Nathalie M. Rieser; Ladina P Gubser; C. Rossgoderer Da Silva; Franz X. Vollenweider; Marcus Herdener; Katrin H. Preller (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial - G. Goodwin; Scott T. Aaronson; Boadie W. Dunlop; D. Feifel; David J. Hellerstein; L. Marwood; S. Mistry; Metten Somers; S.C. Stansfield; J. Tsai; S. Williams; Allan H. Young; et al. (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial - G.M. Goodwin; Scott T. Aaronson; Boadie W. Dunlop; David Feifel; David J. Hellerstein; N. Hewitt; L. Marwood; S. Mistry; Metten Somers; S.C. Stansfield; J. Tsai; S. Williams; et al. (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects - Friederike Holze; A. Becker; Karolina E. Kolaczynska; Urs Duthaler; Matthias E. Liechti (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Rats hallucinate in a similar manner to humans after psilocin - Vejmola Č.; Syrová K.; Šíchová K.; Vlastimil K.; Klučková T.; Kelemen E.; Páleníček T. (Neuroscience Applied, 2021)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com